Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 12, 2008, Pages 1275-1281

  Sinn, D H ^a   Kim, J H ^b   Kim, S ^a   Son, H J ^a   Kim, J J ^a   Rhee, J C ^a   Rhee, P L ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RABEPRAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG MEGADOSE; ENDOSCOPY; ESOPHAGUS MANOMETRY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; GLOBUS HYSTERICUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYMPTOM; THROAT IRRITATION; TREATMENT RESPONSE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 43849096883     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03659.x     Document Type: Article

References (24)

1. Chiocca JC, Olmos JA, Salis GB, Soifer LO, Higa R, Marcolongo M. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study. Aliment Pharmacol Ther 2005 22 : 331 42.
2. Locke GR 3rd., Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112 : 1448 56.
3. Wong WM, Lai KC, Lam KF, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther 2003 18 : 595 604.
4. Rey E, Elola-Olaso CM, Rodriguez-Artalejo F, Locke GR 3rd., Diaz-Rubio M. Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain. Eur J Gastroenterol Hepatol 2006 18 : 969 75.
5. Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA 2005 294 : 1534 40.
6. Chevalier JM, Brossard E, Monnier P. Globus sensation and gastroesophageal reflux. Eur Arch Otorhinolaryngol 2003 260 : 273 6.
7. Corso MJ, Pursnani KG, Mohiuddin MA, et al. Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux. Dig Dis Sci 1998 43 : 1513 7.
8. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006 101 : 1900 20 quiz 43.
9. Bruley des Varannes S. The proton-pump inhibitor test: pros and cons. Eur J Gastroenterol Hepatol 2004 16 : 847 52.
10. Bautista J, Fullerton H, Briseno M, Cui H, Fass R. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain - a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 2004 19 : 1123 30.
11. Kim JH, Rhee PL, Park EH, Son HJ, Kim JJ, Rhee JC. Clinical usefulness of subgrouping of patients with non-cardiac chest pain according to characteristic symptoms in Korea. J Gastroenterol Hepatol 2007 22 : 320 5.
12. The World Congresses of Gastroenterology. Los Angeles, California, 1994. Am J Gastroenterol 1994 89 : S1 193.
13. Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut 2001 49 : 145 51.
14. Hong SN, Rhee PL, Kim JH, et al. Does this patient have oesophageal motility abnormality or pathological acid reflux? Dig Liver Dis 2005 37 : 475 84.
15. Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol 2005 100 : 747 53.
16. Irvine EJ, Whitehead WE, Chey WD, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006 130 : 1538 51.
17. Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005 115 : 1230 8.
18. Bruley des Varannes S, Levy P, Lartigue S, Dellatolas F, Lemaire M, Galmiche JP. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther 1994 8 : 309 14.
19. Noordzij JP, Khidr A, Evans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001 111 : 2147 51.
20. Moser G, Wenzel-Abatzi TA, Stelzeneder M, et al. Globus sensation: pharyngoesophageal function, psychometric and psychiatric findings, and follow-up in 88 patients. Arch Intern Med 1998 158 : 1365 73.
21. Meining A, Bajbouj M, Preeg M, et al. Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial. Endoscopy 2006 38 : 566 70.
22. Knight RE, Wells JR, Parrish RS. Esophageal dysmotility as an important co-factor in extraesophageal manifestations of gastroesophageal reflux. Laryngoscope 2000 110 : 1462 6.
23. Bajbouj M, Becker V, Neuber M, Schmid RM, Meining A. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion 2007 76 : 223 8.
24. Anandasabapathy S, Jaffin BW. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy. Ann Otol Rhinol Laryngol 2006 115 : 563 70.